There will be winners in the commercial world after this is all over and perhaps it could be that those biotechnology companies that have yet to commence human trials will gain an advantage over competitors who before the virus were a step ahead given what has been happening due to OH&S for hospital and research staff and social distancing and isolation needs of patient candidates.
https://www.theaustralian.com.au/business/the-wall-street-journal/coronavirus-delays-testing-of-new-medicines/news-story/34fa395a5fa2d16af950496b36a88291
Ann: PAT-DX1 mechanism for crossing blood brain barrier confirmed, page-20
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $22 | 3.131K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 4673171 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2004772 | 9 |
View Market Depth
| Last trade - 10.06am 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.7¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.7¢ | 0.7¢ | 0.7¢ | 156250 | ||
| Last updated 10.36am 14/06/2024 ? | |||||
| PAB (ASX) Chart |